JAGX · Jaguar Health filed supplemental proxy materials ahead of its November…

Jaguar Health filed supplemental proxy materials ahead of its November 6, 2026 special meeting, disclosing that the board approved a six-fold increase in the share reserve under the 2014 Stock Incentive Plan to offset dilution from a Series R Preferred Stock dividend. If Proposal 3 passes, the plan will have 2,273,154 shares available (up from 378,859), maintaining the intended 14% of fully diluted shares. This filing underscores severe financial distress and massive potential dilution for existing holders.

• Special meeting scheduled for November 6, 2026 to vote on six proposals including a 14% equity incentive plan increase.
• Board approved a six-fold increase in the 2014 Plan share reserve on October 28, 2026, effective after the meeting.
• If Proposal 3 passes, shares available under the plan increase to 2,273,154 (from 378,859).
• Series R Preferred Stock dividend paid October 15, 2026, with automatic conversion into common stock at 5:1 ratio on November 2, 2026.